Robert Kaiden will be resigning from his position as Chief Financial Officer at Inspirato Incorporated (the “Company”) effective as of November 8, 2024.
On October 3, 2024, Ribbon Communications Inc. (the “Company”) announced the appointment of John Townsend as Executive Vice President, Chief Financial Officer of the Company, effective upon the earlier of the filing of the Company’s Form 10-Q for the quarter ended September 30, 2024 and November 1, 2024 (the “Effective Date”).
As previously reported, Miguel Lopez, the Company’s current Executive Vice President, Chief Financial Officer, is retiring from the Company following the filing of the Company’s Form 10-Q for the quarter ended September 30, 2024.
Effective September 30, 2024, Mr. Jornayvaz resigned from all positions with the Company and its subsidiaries and affiliates, including as the Chief Executive Officer and as a member of its Board of Directors (the “Board”).
Joseph La Rosa, the Chief Executive Officer and the Chairman of the Board of Directors (the “Board”), was appointed to also temporarily serve as the interim Chief Financial Officer of the Company while the Company conducts its search for a successor, effective as of October 1, 2024.
Departed
Kent Metzroth
Executive Vice President and Chief Financial Officer
On October 1, 2024, Art’s-Way Manufacturing Co., Inc. (the “Company”) and David A. King, the Company’s Chief Executive Officer since 2020, mutually agreed to terminate Mr. King’s employment agreement and employment with the Company effective immediately.
On October 4, 2024, the Company’s Board of Directors appointed Marc H. McConnell, Chairman of the Company’s Board of Directors, to serve as President and Chief Executive Officer, effective immediately.
Appointed
(interim)
Ari Olgun
Interim Chief Financial Officer
Loop Media, Inc.
Effective
2024-10-01
Filed
October 4, 2024, 7:59 PM ET
Effective October 1, 2024, Mr. Ari Olgun (“ Mr. Olgun ”) was appointed to serve as Interim Chief Financial Officer (“ Interim CFO ”) to fill the vacancy created by Mr. Watanabe’s departure from the Company.
Departed
(interim)
Neil Watanabe
Chief Financial Officer
Loop Media, Inc.
Effective
2024-09-30
Successor
Ari Olgun
Filed
October 4, 2024, 7:59 PM ET
Effective as of September 30, 2024 (the “ Departure Effective Date ”), following the expiration of his employment agreement dated September 30, 2021, Mr. Neil Watanabe (“ Mr. Watanabe ”), the Company’s Chief Financial Officer (“ CFO ”), departed from his role as CFO of the Company after three years of service to pursue other opportunities outside of the Company.
Appointed
Vincent Paul (VP) Berger II
Executive Vice President and Chief Financial Officer
On October 1, 2024, the Board of Directors appointed Vincent Paul (VP) Berger II as Executive Vice President (“EVP”) and CFO, effective December 29, 2024, to succeed Mr. Bridges as the Corporation’s principal financial officer.
On September 27, 2024, Marshall H. Bridges notified HNI Corporation (the “Corporation” or “HNI”) of his decision to retire as Senior Vice President (“SVP”) and Chief Financial Officer (“CFO”), effective December 28, 2024.
Departed
Brian Scott
Executive Vice President and Chief Financial Officer
On September 30, 2024, Brian Scott notified the Company of his intention to resign from his position as the Company’s Executive Vice President and Chief Financial Officer, effective November 20, 2024.
Dawn Hooper, the Company’s Senior Vice President, Controller will serve as the Company’s interim principal financial officer effective November 1, 2024, and as Interim Chief Financial Officer effective upon Mr. Scott’s departure until such time that a successor Chief Financial Officer is appointed.
Appointed
Brian Scott
Chief Financial Officer and Chief Operating Officer
On October 3, 2024, AMN Healthcare Services, Inc. (“AMN” or the “Company”) announced that Brian Scott will join AMN as its Chief Financial Officer and Chief Operating Officer (“CFO/COO”) reporting to Cary Grace, AMN’s President and Chief Executive Officer.
the departure of Jeffrey Knudson from his role as the Company’s CFO, effective November 8, 2024, to pursue an opportunity with a private company outside of the healthcare industry.
Appointed
Travis B. Johnson
Chief Financial Officer and Chief Accounting Officer
the following individuals were elected as officers of the Company in each case until their successors are chosen and qualify in their stead or until their earlier death, resignation or removal: ● Jill Bruning, Chief Technology Officer ● Steven J. Demetriou, Executive Chair ● John Heller, Chief Executive Officer ● Travis B. Johnson, Chief Financial Officer and Chief Accounting Officer ● Sean Mullen, Chief Growth Officer ● Stuart I. Young, Chief Legal Officer
the following individuals were elected as officers of the Company in each case until their successors are chosen and qualify in their stead or until their earlier death, resignation or removal: ● Jill Bruning, Chief Technology Officer ● Steven J. Demetriou, Executive Chair ● John Heller, Chief Executive Officer ● Travis B. Johnson, Chief Financial Officer and Chief Accounting Officer ● Sean Mullen, Chief Growth Officer ● Stuart I. Young, Chief Legal Officer
On October 1, 2024, the board of directors (the “Board”) of IRIDEX Corporation (the “Company”) appointed Patrick Mercer as its Chief Executive Officer and designated Mr. Mercer as the Company’s principal executive officer for purposes of the rules and regulations of the Securities and Exchange Commission (the “SEC”), effective as of such date, replacing David I. Bruce in such roles.
Departed
Sheamus Toal
Chief Operating Officer and Chief Financial Officer
On October 3, 2024, the Company also announced that Sheamus Toal will be leaving his positions as Chief Operating Officer and Chief Financial Officer, effective December 13, 2024.
Appointed
Mary Beth Harler, M.D.
Chief Executive Officer and Director
IGM Biosciences, Inc.
Effective
2024-09-30
Filed
October 3, 2024, 7:59 PM ET
Mary Beth Harler, M.D. has been appointed as the Company’s Chief Executive Officer, effective as of the Effective Date, and as a member of the Board (initial term ending at the annual stockholder meeting in 2025), effective as of October 1, 2024.
Departed
Fred Schwarzer
Chief Executive Officer, President and Director
IGM Biosciences, Inc.
Effective
2024-09-30
Successor
Mary Beth Harler, M.D.
Filed
October 3, 2024, 7:59 PM ET
In connection with the Strategic Pivot, Fred Schwarzer resigned as Chief Executive Officer, President and a member of the board of directors (the “Board”) of the Company, effective as of September 30, 2024 (the “Effective Date”).
William J. Skrobacz will step down as Vice President and Chief Financial Officer of the Company effective December 31, 2024, as he intends to retire from the Company in 2025.
The Company also announced that, effective January 1, 2025, Timothy K. Fitzgerald will succeed Mr. Skrobacz as Vice President and Chief Financial Officer of the Company.
Departed
Michael A. Coates
Chief Financial Officer
U.S. Lighting Group, Inc.
Effective
2024-09-27
Filed
October 3, 2024, 7:59 PM ET
On September 27, 2024, Joseph Matozzo and Michael A. Coates stepped down as the chief executive officer and chief financial officer, respectively
Departed
(interim)
Joseph Matozzo
Chief Executive Officer
U.S. Lighting Group, Inc.
Effective
2024-09-27
Filed
October 3, 2024, 7:59 PM ET
On September 27, 2024, Joseph Matozzo and Michael A. Coates stepped down as the chief executive officer and chief financial officer, respectively
on August 1, 2024, Michael Guthrie, the Company’s Chief Financial Officer, notified Roblox Corporation (the “Company”) of his intent to resign as Chief Financial Officer to pursue personal interests.
He succeeds John C. Fortson, who departed as President and Chief Executive Officer and has resigned as a member of the Board, effective as of October 2, 2024.
Appointed
(interim)
Mark Goldstone
Interim President and Interim Chief Executive Officer
Guardion Health Sciences, Inc.
Effective
2024-10-18
Filed
October 3, 2024, 7:59 PM ET
On October 1, 2024, the Company announced the appointment of Mark Goldstone, a member of the Company’s board of directors, to serve as the Company’s Interim President and Interim Chief Executive Officer, effective October 18, 2024.
appointed James B. Frakes to serve as the Company’s permanent Chief Executive Officer
Appointed
Katharyn Field
Vice President (principal executive officer)
Virpax Pharmaceuticals, Inc.
Effective
2024-09-27
Filed
October 3, 2024, 7:59 PM ET
On September 27, 2024, the Board of Directors (the “Board”) of Virpax Pharmaceuticals, Inc. (the “Company”) appointed Katharyn Field, a member of the Board, to also serve as a Vice President (principal executive officer) of the Company, effective immediately.
On October 1, 2024, Mitek Systems, Inc. (the “Company”) announced that Edward H. West was appointed as the Company’s Chief Executive Officer, effective immediately.
On October 2, 2024, Murphy Oil Corporation (the “Company”) announced that the Board of Directors (the “Board”) has unanimously appointed Eric M. Hambly, currently the Company's President and Chief Operating Officer, as the President and Chief Executive Officer, effective as of January 1, 2025, and has also elected Mr. Hambly to the Board, effective as of January 1, 2025.
Mr. Hambly will be succeeding Roger W. Jenkins, who will be retiring as Chief Executive Officer of the Company and as a member of the Board, effective as of December 31, 2024, and thereafter is expected to serve as a non-executive employee.
Appointed
Daniel Brian
Chief Financial Officer, Treasurer and Secretary
Augmedix, Inc.
Effective
2024-10-02
Filed
October 2, 2024, 7:59 PM ET
Effective at the completion of the Merger, Tanay Tandon became President and Chief Executive Officer, Daniel Brian became Chief Financial Officer, Treasurer and Secretary and Deepika Bodapati became Chief Operating Officer of the Company.
Appointed
Tanay Tandon
President and Chief Executive Officer
Augmedix, Inc.
Effective
2024-10-02
Filed
October 2, 2024, 7:59 PM ET
Effective at the completion of the Merger, Tanay Tandon became President and Chief Executive Officer, Daniel Brian became Chief Financial Officer, Treasurer and Secretary and Deepika Bodapati became Chief Operating Officer of the Company.
Departed
Conor M. Fennerty
Executive Vice President, Chief Financial Officer and Treasurer
Conor M. Fennerty, Executive Vice President, Chief Financial Officer and Treasurer of SITE Centers, and Christina M. Yarian, Senior Vice President and Chief Accounting Officer of SITE Centers, resigned from the Company, effective as of September 30, 2024.
Appointed
Gerald R. Morgan
Executive Vice President, Chief Financial Officer and Treasurer
On the Spin Off Date, the Board appointed Gerald R. Morgan as Executive Vice President, Chief Financial Officer and Treasurer of SITE Centers and Jeffrey A. Scott as Senior Vice President and Chief Accounting Officer of SITE Centers, each effective as of the Spin Off Date.
On September 30, 2024, the Board appointed Georgia Erbez as the Company’s Chief Financial Officer, replacing Sriram Ryali in such role, effective September 30, 2024.
On September 30, 2024, the Board appointed Georgia Erbez as the Company’s Chief Financial Officer, replacing Sriram Ryali in such role, effective September 30, 2024.
On September 30, 2024, the Board of Directors (the “Board”) of the Company notified Brent Bellm that his employment as the Company’s Chief Executive Officer was terminated.
On September 30, 2024, the Board appointed Travis Hess, previously President of the Company, to succeed Mr. Bellm as the Company’s Chief Executive Officer, effective October 1, 2024.
On September 26, 2024, Evan Bloomberg was nominated as Director of the Company and appointed CEO of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.